ZSHK

ZSHK, established by the core team of the Safety Evaluation Center of the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, is a one-stop R&D service platform primarily engaged in preclinical research and evaluation services for biopharmaceuticals and medical devices. It provides services including pharmacological efficacy studies, pharmacokinetic research, and safety evaluation. Headquartered in Hong Kong, China, the company operates independent laboratories in three locations: Hong Kong Science Park, Pingshan District in Shenzhen, Guangdong Province, and Suzhou Industrial Park in Jiangsu Province. At the same time, it actively develops its supply chain to meet the multi-level and multi-faceted needs of customers in different regions for pharmaceutical and device R&D. Currently, ZSHK's preclinical drug evaluation service laboratory in Suzhou Industrial Park has been put into operation. The drug evaluation laboratory at Hong Kong Science Park (the only facility in Hong Kong for preclinical safety evaluation) and the new drug and medical device evaluation laboratory in Pingshan, Shenzhen, are set to officially commence operations in the second half of this year.